The Role of Molecular Imaging in Drug Discovery and DevelopmentJapanese-originated pharmaceutical products in the United States from 1960 to 1989: an assessment of innovation.Glutathione S-transferase mu polymorphism does not explain variation in nitroglycerin responsivenessClinical Pharmacogenetics Implementation Consortium Guidelines for HLA-B Genotype and Abacavir Dosing: 2014 updateSLCO1B1 genetic variant associated with statin-induced myopathy: a proof-of-concept study using the clinical practice research datalinkA meta-analysis of CYP2D6 metabolizer phenotype and metoprolol pharmacokineticsClinical Pharmacogenetics Implementation Consortium guideline for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressantsPharmacogenomics knowledge for personalized medicineAcetaminophen-associated hepatic injury: evaluation of acetaminophen protein adducts in children and adolescents with acetaminophen overdoseClinical Pharmacogenetics Implementation Consortium guidelines for human leukocyte antigen-B genotype and allopurinol dosingCPIC: Clinical Pharmacogenetics Implementation Consortium of the Pharmacogenomics Research NetworkClinical Pharmacogenetics Implementation Consortium guidelines for thiopurine methyltransferase genotype and thiopurine dosingCYP2B6 and bupropion's smoking-cessation pharmacology: the role of hydroxybupropionPreclinical pharmacology and toxicology of intravenous MV-NIS, an oncolytic measles virus administered with or without cyclophosphamideWarfarin with fluoroquinolones, sulfonamides, or azole antifungals: interactions and the risk of hospitalization for gastrointestinal bleedinglncRNA/MicroRNA interactions in the vasculatureLeveraging big data to transform target selection and drug discoveryPolyallelic structural variants can provide accurate, highly informative genetic markers focused on diagnosis and therapeutic targets: Accuracy vs. PrecisionClinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for UGT1A1 and Atazanavir PrescribingCardiovascular Risk in Diabetes Mellitus: Complication of the Disease or of Antihyperglycemic MedicationsThe 1200 patients project: creating a new medical model system for clinical implementation of pharmacogenomicsNetwork-based approaches in drug discovery and early developmentCannabinoid abuse and addiction: Clinical and preclinical findingsDeveloping new drug treatments in the era of network medicineA health-care system perspective on implementing genomic medicine: pediatric acute lymphoblastic leukemia as a paradigmPersonalized cancer medicine: molecular diagnostics, predictive biomarkers, and drug resistanceTranslational bioinformatics: linking the molecular world to the clinical worldClinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C9 and VKORC1 genotypes and warfarin dosingNeonatal drug therapy: The first frontier of therapeutics for childrenPhenotype standardization for statin-induced myotoxicityGene therapy targets in heart failure: the path to translationAutoimmunity and Graves' diseaseITC recommendations for transporter kinetic parameter estimation and translational modeling of transport-mediated PK and DDIs in humansCFTR inhibitors for treating diarrheal diseaseNovel nerve-agent antidote design based on crystallographic and mass spectrometric analyses of tabun-conjugated acetylcholinesterase in complex with antidotesTreatment of osteoarthritis with aspartameThiopurine pharmacogenetics in leukemia: correlation of erythrocyte thiopurine methyltransferase activity and 6-thioguanine nucleotide concentrationsDigital technologies for cognitive assessment to accelerate drug development in Alzheimer's diseaseInfluence of grapefruit juice on cisapride pharmacokineticsGrapefruit juice increases serum concentrations of atorvastatin and has no effect on pravastatin
P1433
Q22121985-F54E08F8-259B-4260-9DB0-506831345EB1Q22122310-E0CC8FC0-249A-4B29-AAA9-D5EC3BE7D92EQ23923528-91DD687A-C3D9-417C-88F4-F36A64B121ACQ24567766-C76325EB-EB51-435E-8B97-D1C81F6DCD41Q24598793-5D29D1F5-7E7A-4514-8C12-AD3A6255F6F9Q24602122-40D12AA1-4235-4232-BEAC-FA58D24ED334Q24610169-572D6F65-A9D8-4A34-80EB-123BC0C73117Q24623166-3AA84DEB-30DB-4DDD-B674-9B9F41928D89Q24624026-51EBE4A8-9EEB-4D3A-B81A-3DD6FD6B5A5BQ24626941-0E671A57-D671-4AB4-AE8E-A226D994D42FQ24632735-FFB52240-7B1D-4359-B9CF-799EC745FF53Q24632749-6847D26A-CBD4-4B89-9435-5939F5B33C13Q24634660-5688A2DC-28E6-47D1-94C2-7319B1518AD7Q24647228-C9A9A8E8-5292-45BE-BC4A-2A670CA5F96BQ24647605-070238F4-D172-441A-BFCD-12C2814410ADQ26766577-9EF25000-07EC-4717-86F5-1A4B0D0E7830Q26776403-9CAB930A-B181-4E4B-B6AE-49508FC55D53Q26777805-C19FD2A7-46DC-400F-A454-FC842E846F02Q26784507-18424572-EC25-40EC-B071-1BF7FAC10565Q26824616-D512A594-D1D1-4C22-B460-51AE28546836Q26825275-F2F58593-608F-4952-97F1-0FA8937B1417Q26827940-92AE0B96-693B-4334-9421-BC28C1EF8BC4Q26851944-AAA661F6-57B1-4DF8-87F9-98EA2F711334Q26865960-88DEC452-9E73-41C4-9241-150BACF18840Q26866379-FB91F8EF-2370-4CF3-8FE0-6163222B0676Q26866517-258B327F-7141-413D-8DC9-ACBF50E8BDACQ27002440-113C7842-63A2-4BC7-A519-EDB7956D4363Q27008360-F5DF9FF9-DBE9-4C54-B3CB-DFF3B5988D21Q27013749-BF50CC14-A507-413A-8BE1-08711FDCBD18Q27020935-AB333DFA-3911-4ABE-9568-8B1DB044C447Q27022444-0A8C5036-8FB5-4591-905B-3C2C6333663BQ27022771-18B5D202-1D89-440E-8F94-88BB3EEB447FQ27022933-48E624B5-0F07-4E07-B491-2181C52F0A9FQ27026626-72AE30E9-954F-478E-92AD-63D5E6870416Q27644500-45668465-7093-480A-8B31-3F61BEA73BD0Q27758942-44C024C2-F65B-4AB4-A493-6731DA7E8727Q27820693-44A0A264-7829-40F1-B301-884A0F10B1D6Q28081484-F3CBAEEC-8DBE-40BF-A062-D7054C1E85A3Q28142774-EF92702C-E11C-463D-89EB-596C39D326E8Q28142865-A14E5D1E-B4E7-4D2F-B127-F9951ABD9276
P1433
description
Wissenschaftliche Fachzeitschrift
@de
journal
@en
revista científica
@es
rivista scientifica
@it
vědecký časopis
@cs
wetenschappelijk tijdschrift van Nature Publishing Group
@nl
مجلة
@ar
वैज्ञानिक पत्रिका
@hi
英语期刊
@zh
name
Clinical Pharmacology & Therapeutics
@ast
Clinical Pharmacology & Therapeutics
@da
Clinical Pharmacology & Therapeutics
@de
Clinical Pharmacology & Therapeutics
@en
Clinical Pharmacology & Therapeutics
@es
Clinical Pharmacology & Therapeutics
@fi
Clinical Pharmacology & Therapeutics
@fr
Clinical Pharmacology & Therapeutics
@it
Clinical Pharmacology & Therapeutics
@nb
Clinical Pharmacology & Therapeutics
@nl
type
label
Clinical Pharmacology & Therapeutics
@ast
Clinical Pharmacology & Therapeutics
@da
Clinical Pharmacology & Therapeutics
@de
Clinical Pharmacology & Therapeutics
@en
Clinical Pharmacology & Therapeutics
@es
Clinical Pharmacology & Therapeutics
@fi
Clinical Pharmacology & Therapeutics
@fr
Clinical Pharmacology & Therapeutics
@it
Clinical Pharmacology & Therapeutics
@nb
Clinical Pharmacology & Therapeutics
@nl
altLabel
Clin Pharmacol Ther
@de
Clin. Pharmacol. Ther.
@fr
Clinical Pharmacology and Therapeutics
@de
Clinical Pharmacology and Therapeutics
@en
Clinical Pharmacology and Therapeutics
@fr
Clinical pharmacology and therapeutics
@de
Clinical pharmacology and therapeutics
@fr
prefLabel
Clinical Pharmacology & Therapeutics
@ast
Clinical Pharmacology & Therapeutics
@da
Clinical Pharmacology & Therapeutics
@de
Clinical Pharmacology & Therapeutics
@en
Clinical Pharmacology & Therapeutics
@es
Clinical Pharmacology & Therapeutics
@fi
Clinical Pharmacology & Therapeutics
@fr
Clinical Pharmacology & Therapeutics
@it
Clinical Pharmacology & Therapeutics
@nb
Clinical Pharmacology & Therapeutics
@nl
P243
P3181
P4616
P101
P1055
P1058
P1144
P1156
P1159
P1160
Clin. Pharmacol. Ther.
P1250
P1277
P1476
Clinical Pharmacology & Therapeutics
@en